Skip to main content
. 2017 Mar 17;26(8):2237–2244. doi: 10.1007/s11136-017-1544-2

Table 3.

Distribution of the patient-reported symptoms associated with chordoma by tumor location

Symptom All (n = 327) (%) Chordoma tumor location
Skull base (n = 131) (%) Mobile spinea (n = 92) (%) Sacrum or Coccyx (n = 101) (%) Otherb (n = 3) (%) P-valuec
Chronic pain (n = 123) 38 14 57 51 33 0.001
Depression or severe anxiety (n = 113) 35 35 37 31 67 0.489
Chronic fatigue (n = 110) 34 30 39 33 67 0.269
Difficulty walking (n = 100) 31 7 40 54 67 0.001
Balance impairment (n = 94) 29 33 26 25 67 0.205
Difficulty sitting (n = 85) 26 2 20 62 33 0.001
Double vision (n = 76) 23 56 1 2 0 0.001
Sexual dysfunction (n = 74) 23 15 10 46 0 0.001
Limited mobility (n = 63) 19 3 33 29 0 0.001
Urinary incontinence (n = 52) 16 2 2 48 0 0.001
Chronic sinus problems (n = 46) 14 34 1 0 0 0.001
Urinary retention (n = 46) 14 1 3 42 0 0.001
Hearing loss (n = 44) 13 32 1 1 0 0.001
Fecal incontinence (n = 41) 13 0 1 40 0 0.001
Bowel obstruction (n = 38) 12 2 7 30 0 0.001
Other vision problems (n = 28) 9 16 3 4 0 0.002

Symptoms were asked using the following survey question: “Which of the following health effects have you ever suffered as a result of chordoma?”

a Includes neck, mid back, and lower back

b Includes extra-axial, multifocal, or unknown

c P-values were calculated using Fisher’s exact test